Does atorvastatin have augmentative effects with sodium valproate in prevention of migraine with aura attacks? A triple-blind controlled clinical trial.

Ganji, Reza; Majdinasab, Nastaran; Hesam, Saeed; Rostami, Nazanin; Sayyah, Mehdi; Sahebnasagh, Adeleh

Ganji, Reza; Majdinasab, Nastaran; Hesam, Saeed; Rostami, Nazanin; Sayyah, Mehdi; Sahebnasagh, Adeleh.

Afiliação

Ganji R; Department of Clinical Pharmacy, Faculty of Pharmacy, Jundishapur University of Medical Sciences, Ahvaz, Iran.
Majdinasab N; Musculoskeletal Rehabilitation Research Center, Department of Neurology, Jundishapur University of Medical Sciences, Ahvaz, Iran.
Hesam S; Department of Biostatistics and Epidemiology, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Rostami N; Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Sayyah M; Education Development Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Sahebnasagh A; Clinical Research Center, Department of Internal Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran. masoomehsahebnasagh@gmail.coma.

J Pharm Health Care Sci ; 7(1): 12, 2021 Apr 01.

Article em En | MEDLINE | ID: mdl-33789774

Palavras-chave

Atorvastatin; Headache; Migraine with Aura; Prophylaxis; Sodium valproate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: J Pharm Health Care Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google